nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.194	0.356	CbGbCtD
Nepafenac—PTGS2—Etoposide—peripheral nervous system neoplasm	0.191	0.349	CbGbCtD
Nepafenac—PTGS1—Etoposide—peripheral nervous system neoplasm	0.161	0.295	CbGbCtD
Nepafenac—Dry eye syndrome—Isotretinoin—peripheral nervous system neoplasm	0.027	0.0596	CcSEcCtD
Nepafenac—Dry eye syndrome—Tretinoin—peripheral nervous system neoplasm	0.027	0.0596	CcSEcCtD
Nepafenac—Dry eye syndrome—Alitretinoin—peripheral nervous system neoplasm	0.0205	0.0452	CcSEcCtD
Nepafenac—Lacrimation decreased—Tretinoin—peripheral nervous system neoplasm	0.0155	0.0343	CcSEcCtD
Nepafenac—Lacrimation decreased—Isotretinoin—peripheral nervous system neoplasm	0.0155	0.0343	CcSEcCtD
Nepafenac—Teratogenicity—Tretinoin—peripheral nervous system neoplasm	0.0122	0.0268	CcSEcCtD
Nepafenac—Teratogenicity—Isotretinoin—peripheral nervous system neoplasm	0.0122	0.0268	CcSEcCtD
Nepafenac—Lacrimation decreased—Alitretinoin—peripheral nervous system neoplasm	0.0118	0.026	CcSEcCtD
Nepafenac—Corneal opacity—Tretinoin—peripheral nervous system neoplasm	0.00976	0.0215	CcSEcCtD
Nepafenac—Corneal opacity—Isotretinoin—peripheral nervous system neoplasm	0.00976	0.0215	CcSEcCtD
Nepafenac—Teratogenicity—Alitretinoin—peripheral nervous system neoplasm	0.00921	0.0203	CcSEcCtD
Nepafenac—Scab—Tretinoin—peripheral nervous system neoplasm	0.00801	0.0177	CcSEcCtD
Nepafenac—Scab—Isotretinoin—peripheral nervous system neoplasm	0.00801	0.0177	CcSEcCtD
Nepafenac—Corneal opacity—Alitretinoin—peripheral nervous system neoplasm	0.0074	0.0163	CcSEcCtD
Nepafenac—Scab—Alitretinoin—peripheral nervous system neoplasm	0.00607	0.0134	CcSEcCtD
Nepafenac—Impaired healing—Isotretinoin—peripheral nervous system neoplasm	0.00589	0.013	CcSEcCtD
Nepafenac—Impaired healing—Tretinoin—peripheral nervous system neoplasm	0.00589	0.013	CcSEcCtD
Nepafenac—Impaired healing—Melphalan—peripheral nervous system neoplasm	0.00581	0.0128	CcSEcCtD
Nepafenac—Ocular hyperaemia—Tretinoin—peripheral nervous system neoplasm	0.00543	0.012	CcSEcCtD
Nepafenac—Ocular hyperaemia—Isotretinoin—peripheral nervous system neoplasm	0.00543	0.012	CcSEcCtD
Nepafenac—Endophthalmitis—Tretinoin—peripheral nervous system neoplasm	0.00535	0.0118	CcSEcCtD
Nepafenac—Endophthalmitis—Isotretinoin—peripheral nervous system neoplasm	0.00535	0.0118	CcSEcCtD
Nepafenac—Pregnancy—Tretinoin—peripheral nervous system neoplasm	0.00449	0.00991	CcSEcCtD
Nepafenac—Pregnancy—Isotretinoin—peripheral nervous system neoplasm	0.00449	0.00991	CcSEcCtD
Nepafenac—Impaired healing—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00985	CcSEcCtD
Nepafenac—Visual acuity reduced—Tretinoin—peripheral nervous system neoplasm	0.00428	0.00945	CcSEcCtD
Nepafenac—Visual acuity reduced—Isotretinoin—peripheral nervous system neoplasm	0.00428	0.00945	CcSEcCtD
Nepafenac—Blepharitis—Tretinoin—peripheral nervous system neoplasm	0.00414	0.00914	CcSEcCtD
Nepafenac—Blepharitis—Isotretinoin—peripheral nervous system neoplasm	0.00414	0.00914	CcSEcCtD
Nepafenac—Ocular hyperaemia—Alitretinoin—peripheral nervous system neoplasm	0.00412	0.00909	CcSEcCtD
Nepafenac—Endophthalmitis—Alitretinoin—peripheral nervous system neoplasm	0.00406	0.00895	CcSEcCtD
Nepafenac—Keratitis—Tretinoin—peripheral nervous system neoplasm	0.00393	0.00867	CcSEcCtD
Nepafenac—Keratitis—Isotretinoin—peripheral nervous system neoplasm	0.00393	0.00867	CcSEcCtD
Nepafenac—Dermatitis atopic—Tretinoin—peripheral nervous system neoplasm	0.00344	0.0076	CcSEcCtD
Nepafenac—Dermatitis atopic—Isotretinoin—peripheral nervous system neoplasm	0.00344	0.0076	CcSEcCtD
Nepafenac—Pregnancy—Alitretinoin—peripheral nervous system neoplasm	0.0034	0.00751	CcSEcCtD
Nepafenac—Dermatitis atopic—Melphalan—peripheral nervous system neoplasm	0.0034	0.0075	CcSEcCtD
Nepafenac—Visual acuity reduced—Alitretinoin—peripheral nervous system neoplasm	0.00325	0.00716	CcSEcCtD
Nepafenac—Blepharitis—Alitretinoin—peripheral nervous system neoplasm	0.00314	0.00693	CcSEcCtD
Nepafenac—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00658	CcSEcCtD
Nepafenac—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00658	CcSEcCtD
Nepafenac—Keratitis—Alitretinoin—peripheral nervous system neoplasm	0.00298	0.00657	CcSEcCtD
Nepafenac—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.00276	0.0061	CcSEcCtD
Nepafenac—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.00276	0.0061	CcSEcCtD
Nepafenac—Cataract—Tretinoin—peripheral nervous system neoplasm	0.00268	0.00591	CcSEcCtD
Nepafenac—Cataract—Isotretinoin—peripheral nervous system neoplasm	0.00268	0.00591	CcSEcCtD
Nepafenac—Dermatitis atopic—Alitretinoin—peripheral nervous system neoplasm	0.00261	0.00576	CcSEcCtD
Nepafenac—Photophobia—Tretinoin—peripheral nervous system neoplasm	0.00239	0.00528	CcSEcCtD
Nepafenac—Photophobia—Isotretinoin—peripheral nervous system neoplasm	0.00239	0.00528	CcSEcCtD
Nepafenac—Dry eye—Tretinoin—peripheral nervous system neoplasm	0.00235	0.00519	CcSEcCtD
Nepafenac—Dry eye—Isotretinoin—peripheral nervous system neoplasm	0.00235	0.00519	CcSEcCtD
Nepafenac—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00499	CcSEcCtD
Nepafenac—Diabetes mellitus—Tretinoin—peripheral nervous system neoplasm	0.00213	0.00469	CcSEcCtD
Nepafenac—Diabetes mellitus—Isotretinoin—peripheral nervous system neoplasm	0.00213	0.00469	CcSEcCtD
Nepafenac—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.00462	CcSEcCtD
Nepafenac—Cataract—Alitretinoin—peripheral nervous system neoplasm	0.00203	0.00448	CcSEcCtD
Nepafenac—Arthritis—Tretinoin—peripheral nervous system neoplasm	0.0019	0.0042	CcSEcCtD
Nepafenac—Arthritis—Isotretinoin—peripheral nervous system neoplasm	0.0019	0.0042	CcSEcCtD
Nepafenac—Photophobia—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.004	CcSEcCtD
Nepafenac—Dry eye—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00394	CcSEcCtD
Nepafenac—Diabetes mellitus—Alitretinoin—peripheral nervous system neoplasm	0.00161	0.00356	CcSEcCtD
Nepafenac—Arthritis—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00318	CcSEcCtD
Nepafenac—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00317	CcSEcCtD
Nepafenac—Sinusitis—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00295	CcSEcCtD
Nepafenac—Sinusitis—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00295	CcSEcCtD
Nepafenac—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00293	CcSEcCtD
Nepafenac—Keratitis—Epirubicin—peripheral nervous system neoplasm	0.0013	0.00287	CcSEcCtD
Nepafenac—Keratitis—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00266	CcSEcCtD
Nepafenac—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.0012	0.00264	CcSEcCtD
Nepafenac—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.00264	CcSEcCtD
Nepafenac—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.00117	0.00258	CcSEcCtD
Nepafenac—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.00116	0.00257	CcSEcCtD
Nepafenac—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00256	CcSEcCtD
Nepafenac—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00256	CcSEcCtD
Nepafenac—Dermatitis atopic—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00252	CcSEcCtD
Nepafenac—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.00114	0.00252	CcSEcCtD
Nepafenac—Dermatitis atopic—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00233	CcSEcCtD
Nepafenac—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00232	CcSEcCtD
Nepafenac—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00232	CcSEcCtD
Nepafenac—Sinusitis—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00224	CcSEcCtD
Nepafenac—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000962	0.00212	CcSEcCtD
Nepafenac—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000962	0.00212	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000949	0.00209	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000942	0.00208	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000942	0.00208	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000929	0.00205	CcSEcCtD
Nepafenac—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.000927	0.00205	CcSEcCtD
Nepafenac—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.000927	0.00205	CcSEcCtD
Nepafenac—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.000917	0.00202	CcSEcCtD
Nepafenac—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.000906	0.002	CcSEcCtD
Nepafenac—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000899	0.00198	CcSEcCtD
Nepafenac—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000891	0.00197	CcSEcCtD
Nepafenac—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000891	0.00197	CcSEcCtD
Nepafenac—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00089	0.00196	CcSEcCtD
Nepafenac—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000883	0.00195	CcSEcCtD
Nepafenac—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000883	0.00195	CcSEcCtD
Nepafenac—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00088	0.00194	CcSEcCtD
Nepafenac—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000871	0.00192	CcSEcCtD
Nepafenac—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.000848	0.00187	CcSEcCtD
Nepafenac—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000848	0.00187	CcSEcCtD
Nepafenac—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000795	0.00176	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000791	0.00175	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000785	0.00173	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000785	0.00173	CcSEcCtD
Nepafenac—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.00078	0.00172	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000775	0.00171	CcSEcCtD
Nepafenac—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000772	0.0017	CcSEcCtD
Nepafenac—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000746	0.00165	CcSEcCtD
Nepafenac—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000729	0.00161	CcSEcCtD
Nepafenac—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.00159	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000714	0.00158	CcSEcCtD
Nepafenac—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000707	0.00156	CcSEcCtD
Nepafenac—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000705	0.00156	CcSEcCtD
Nepafenac—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000703	0.00155	CcSEcCtD
Nepafenac—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000702	0.00155	CcSEcCtD
Nepafenac—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000687	0.00152	CcSEcCtD
Nepafenac—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000684	0.00151	CcSEcCtD
Nepafenac—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000679	0.0015	CcSEcCtD
Nepafenac—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000678	0.0015	CcSEcCtD
Nepafenac—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.00149	CcSEcCtD
Nepafenac—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000675	0.00149	CcSEcCtD
Nepafenac—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00067	0.00148	CcSEcCtD
Nepafenac—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00067	0.00148	CcSEcCtD
Nepafenac—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000669	0.00148	CcSEcCtD
Nepafenac—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000661	0.00146	CcSEcCtD
Nepafenac—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000652	0.00144	CcSEcCtD
Nepafenac—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000651	0.00144	CcSEcCtD
Nepafenac—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000648	0.00143	CcSEcCtD
Nepafenac—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000643	0.00142	CcSEcCtD
Nepafenac—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000643	0.00142	CcSEcCtD
Nepafenac—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000635	0.0014	CcSEcCtD
Nepafenac—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.00139	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000608	0.00134	CcSEcCtD
Nepafenac—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000606	0.00134	CcSEcCtD
Nepafenac—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000601	0.00133	CcSEcCtD
Nepafenac—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000601	0.00133	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000595	0.00131	CcSEcCtD
Nepafenac—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000583	0.00129	CcSEcCtD
Nepafenac—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000578	0.00128	CcSEcCtD
Nepafenac—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000578	0.00128	CcSEcCtD
Nepafenac—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000576	0.00127	CcSEcCtD
Nepafenac—Headache—Topotecan—peripheral nervous system neoplasm	0.000574	0.00127	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000573	0.00126	CcSEcCtD
Nepafenac—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00057	0.00126	CcSEcCtD
Nepafenac—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00057	0.00126	CcSEcCtD
Nepafenac—Headache—Tretinoin—peripheral nervous system neoplasm	0.000569	0.00126	CcSEcCtD
Nepafenac—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000569	0.00126	CcSEcCtD
Nepafenac—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000569	0.00126	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000557	0.00123	CcSEcCtD
Nepafenac—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000547	0.00121	CcSEcCtD
Nepafenac—Nausea—Topotecan—peripheral nervous system neoplasm	0.000544	0.0012	CcSEcCtD
Nepafenac—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00054	0.00119	CcSEcCtD
Nepafenac—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00054	0.00119	CcSEcCtD
Nepafenac—Nausea—Melphalan—peripheral nervous system neoplasm	0.000533	0.00118	CcSEcCtD
Nepafenac—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000522	0.00115	CcSEcCtD
Nepafenac—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000508	0.00112	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000507	0.00112	CcSEcCtD
Nepafenac—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000489	0.00108	CcSEcCtD
Nepafenac—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000487	0.00108	CcSEcCtD
Nepafenac—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000472	0.00104	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000464	0.00102	CcSEcCtD
Nepafenac—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000456	0.00101	CcSEcCtD
Nepafenac—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000979	CcSEcCtD
Nepafenac—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000441	0.000974	CcSEcCtD
Nepafenac—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000439	0.000969	CcSEcCtD
Nepafenac—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000438	0.000967	CcSEcCtD
Nepafenac—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000432	0.000954	CcSEcCtD
Nepafenac—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000432	0.000952	CcSEcCtD
Nepafenac—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000422	0.000931	CcSEcCtD
Nepafenac—Headache—Vincristine—peripheral nervous system neoplasm	0.000416	0.000918	CcSEcCtD
Nepafenac—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000905	CcSEcCtD
Nepafenac—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000409	0.000903	CcSEcCtD
Nepafenac—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000875	CcSEcCtD
Nepafenac—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000396	0.000874	CcSEcCtD
Nepafenac—Nausea—Vincristine—peripheral nervous system neoplasm	0.000394	0.00087	CcSEcCtD
Nepafenac—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000385	0.00085	CcSEcCtD
Nepafenac—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000846	CcSEcCtD
Nepafenac—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00038	0.00084	CcSEcCtD
Nepafenac—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000373	0.000824	CcSEcCtD
Nepafenac—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.00081	CcSEcCtD
Nepafenac—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000786	CcSEcCtD
Nepafenac—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000356	0.000785	CcSEcCtD
Nepafenac—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000783	CcSEcCtD
Nepafenac—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000349	0.000769	CcSEcCtD
Nepafenac—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000768	CcSEcCtD
Nepafenac—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000342	0.000755	CcSEcCtD
Nepafenac—Headache—Etoposide—peripheral nervous system neoplasm	0.000337	0.000743	CcSEcCtD
Nepafenac—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000711	CcSEcCtD
Nepafenac—Nausea—Etoposide—peripheral nervous system neoplasm	0.000319	0.000705	CcSEcCtD
Nepafenac—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000704	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000689	CcSEcCtD
Nepafenac—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000679	CcSEcCtD
Nepafenac—Mebendazole—ABCB1—peripheral nervous system neoplasm	0.000301	0.524	CrCbGaD
Nepafenac—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000652	CcSEcCtD
Nepafenac—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000651	CcSEcCtD
Nepafenac—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000646	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000638	CcSEcCtD
Nepafenac—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000628	CcSEcCtD
Nepafenac—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000604	CcSEcCtD
Nepafenac—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000598	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000574	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000531	CcSEcCtD
Nepafenac—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00049	CcSEcCtD
Nepafenac—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000471	CcSEcCtD
Nepafenac—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000453	CcSEcCtD
Nepafenac—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00044	CcSEcCtD
Nepafenac—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000435	CcSEcCtD
Nepafenac—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000423	CcSEcCtD
Nepafenac—Headache—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000417	CcSEcCtD
Nepafenac—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000407	CcSEcCtD
Nepafenac—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000395	CcSEcCtD
Nepafenac—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000391	CcSEcCtD
Nepafenac—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000386	CcSEcCtD
Nepafenac—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000366	CcSEcCtD
Nepafenac—Diclofenac—ABCB1—peripheral nervous system neoplasm	0.000147	0.256	CrCbGaD
Nepafenac—Carbamazepine—ABCB1—peripheral nervous system neoplasm	0.000126	0.22	CrCbGaD
